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To exploit these properties, we conducted a genome-wide discovery scan of the association genome-wide level of statistical significance (p<5×10 -08 ) in genes at least 1 Mb apart of each 1 0 0 other (SI Appendix Table S3 and Fig. S2 ). In addition to the main analysis, we also identified 1 0 1 two additional signals in a women-specific analysis (p<5×10 -08 in a women-only secondary 1 0 2 analysis; SI Appendix Table S3 ) and two additional signals that met a Bonferroni-corrected a correction for 37,435 variants tested; SI Appendix Table S3 ). We conducted systematic analyses of genomic context to establish whether the identified 1 0 6 rare nonsynonymous variants are likely to be causal for the association with BMI-adjusted WHR, including conditional analyses and fine-mapping of statistically-decomposed signals (Methods). Fine-mapping analyses provided strong statistical evidence for the causal association of rare 1 0 9 nonsynonymous variants of CALCRL, PLIN1, PDE3B and ACVR1C in the main analysis and of 1 1 0 FGF1 in the experiment-level statistical significance secondary analysis (Table 1, Fig. 1 , and SI 1 1 1 Appendix Fig. S3 ). Conversely, genomic context analyses were not consistent with causal associations for identified rare nonsynonymous variants in ABHD15 (main analysis), PYGM 1 1 3 (main analysis), PLCB3 (experiment-level statistical significance and women-specific secondary 1 1 4 analyses) or FNIP1 (women-specific secondary analysis; all results in SI Appendix Tables S3-7 statistical evidence of causal association for this variant. 1 4 1 At ACVR1C, there was evidence of three distinct signals (Table 1 and Fig. 1 ). The rare 1 4 2 p.I195T variant led one of the secondary signals at this region and was the only variant in the 1 4 3 99% credible set (PPA>99%; Table 1 ). In addition, the primary signal at this region was led by a 1 4 4 low-frequency missense variant in ACVR1C (rs55920843, p.N150H), which also had the highest 1 4 5 posterior probability in fine-mapping of this signal (PPA>99%; Table 1 ). Hence, fine-mapping of 1 4 6 conditionally-independent signals at this locus converges on ACVR1C as causal gene for body fat 1 4 7 distribution and p.I195T and p.N150H as causal variants for the respective association peaks. 1 4 8 Additional consideration of subthreshold-signals that met the experiment-level Bonferroni 1 4 9 correction showed evidence of six conditionally-independent signals in and around the FGF1 1 5 0 gene, one of which was led by the rare p.G21E missense variant (PPA=98%; Table 1 and SI 1 5 1 Appendix Fig. S3 ). 1 5 2 Given previous reports of sex-specific associations with BMI-adjusted WHR (6), we 1 5 3 estimated stratified associations for likely-causal variants identified in our analysis and, in line 1 5 4 with previous studies (6) , found larger effect-size estimates in women compared to men, with a 1 5 5 statistically-significant difference for rs150090666 p.R783X in PDE3B (p heterogeneity =5.2×10 -06 ; SI 1 5 6 Appendix Table S6 ). 1 5 7 In a gene-based analysis, the burden of rare nonsynonymous alleles in PLIN1, the only gene 1 5 8 with other rare nonsynonymous variants in addition to those found in the main analysis, was not 1 5 9 associated with statistically-significant differences in BMI-adjusted WHR (SI Appendix Table  Fig. 2-3, SI Appendix Table S9 ), suggesting that the identified variants may enhance the storage 1 7 7 capacity of gluteofemoral adipose tissue. The four rare nonsynonymous variants were also 1 7 8 associated with other cardio-metabolic phenotypes ( Fig. 2-3) , as described in more detail below. The CALCRL p.L87P variant was associated with higher high-density lipoprotein cholesterol 1 8 0 (HDL-C) and protection from coronary disease (Fig. 2) . The variant occurs near a strictly conserved disulfide cross-link in this G-protein coupled receptor, but leucine 87 itself is not a conserved residue as it is replaced by proline in several species (SI Appendix Box S1), 1 8 3 consistent with integrated evidence from sixteen in silico prediction algorithms (SI Appendix Table S8 ). This suggests that p.L87P has a mild functional impact on this G-protein coupled receptor the knock-out of which is embryonically-lethal in mice (SI Appendix Box S1) (27) . The p.L90P variant in PLIN1, occurring near the conserved serine 81 which is believed to be involved 1 8 7 in the interaction of perilipin 1 with hormone sensitive lipase (SI Appendix Box S1), was experiments showed similar basal-, ABHD5 stimulated-and GOS2-inhibited enzyme activity as well as similar localization to lipid droplets between PNPLA2-N252K and wild-type PNPLA2 2 7 1 ( Fig. 5C and SI Appendix Fig. S8 ), in keeping with structural modelling (SI Appendix Box 2 7 2 S1). However, the C>G substitution occurs at position -2 at the donor splice site of exon 6 in a partially-conserved nucleotide that is never substituted with a G in mammalian species, 2 7 4 suggesting a possible impact on splicing ( Fig. 5D) . In silico software predicted this change to 2 7 5 result in the creation of an exonic splicing silencer site, with higher probability of exon skipping (Methods). We hypothesized that if the variant affected the correct splicing of PNPLA2, this could alter allele-specific expression of PNPLA2 in carriers. To assess this, we investigated the allele-specific expression of PNPLA2 in subcutaneous adipose tissue from four unrelated heterozygous carriers of rs140201358-G from the Twins UK study. Across the four carriers, there 2 8 0 were 2,032 reads of PNPLA2 mRNA in subcutaneous adipose tissue. The number of reads carrying the alternative G allele (i.e. 252K) was 21% lower than that of reads containing the wild- type C allele (observed reads, 900; expected, 1,016; two-tailed binomial p=2.9×10 -07 ), with a 5E). To assess impact on overall expression, we conducted quantitative polymerase chain G allele from the Fenland study. Heterozygous carriers of the G allele had 0.39 standard deviations lower overall levels of PNPLA2 mRNA compared to homozygous wild-type to be established if associations with expression levels do reflect a splicing defect or result from other regulatory mechanisms due to rs140201358 or correlated variants. In gene-based analyses, the one rare nonsynonymous variant in PNPLA2 captured by genotyping (p.S407F) or 10 rare variants in the other intracellular lipolysis genes were not 2 9 4 associated with statistically-significant differences in BMI-adjusted WHR (SI Appendix Table   2 9 5 S7). 2 9 7 By combining human genetics studies in over half a million people with in silico and in vitro 2 9 8 functional analyses, we found evidence implicating intracellular lipolysis genes in the regulation 2 9 9 of fat distribution and its cardio-metabolic consequences in the general population. This genetic 3 0 0 study focused on a subset of genetic variation in order to maximize translational insights of 3 0 1 genetic findings and is distinct from but complementary to genome-wide association studies assessing all genetic variants to clarify the overall genetic architecture of a trait. In addition, given the strict criteria for statistical significance and the systematic analysis of genomic context, imputed datasets, including those appropriate for the analysis of whole genome sequencing a basis for the understanding of the molecular mechanisms behind these robust phenotypic associations. With fine-mapping, we show that five nonsynonymous variants at four of the identified genes (PLIN1, PDE3B, ACVR1C, and PNPLA2, found via targeted follow-up analysis) 3 1 3 had >99% PPA, the highest possible statistical evidence of causal association. Studies in rare forms of human lipodystrophy (36, 39) , in experimental models (40-42) and 3 1 5 recently also in the general population (7, (43) (44) (45) have implicated an impaired capacity to store fat in peripheral adipose compartments in cardio-metabolic disease. Our results highlight intracellular lipolysis as a novel mechanism linking impaired peripheral fat deposition to the risk of cardio-metabolic disease. Intracellular lipolysis is the biochemical process that regulates the release of fatty acid molecules from mature cells and its level of activation ultimately controls the propensity of peripheral adipocytes, and other tissues, to retain energy stores in the form of fat 3 2 1 (46, 47) . Therefore, modulating this pathway determines where and how efficiently surplus 3 2 2 energy is stored and thus the risk of the complications of sustained positive energy balance. In addition, in a secondary analysis of this study we found evidence of a likely-causal association 3 2 4 with lower BMI-adjusted WHR of a rare missense variant in FGF1, a gene that murine 3 2 5 experiments have implicated in the remodeling of adipose tissue in response to fluctuations in 3 2 6 nutrient availability (48) . In addition to previous evidence about the role of adipogenesis and intravascular lipolysis (7), findings from this study around intracellular lipolysis and the FGF1- pathway highlight the importance of adipose tissue plasticity in response to energy availability as 3 2 9 a critical mechanism in the determination of fat distribution and its cardio-metabolic
Discussion
All four likely-causal genes identified in our hypothesis-free main-analysis of rare, intracellular triglyceride hydrolysis, was associated with unfavorable fat distribution, higher 3 3 5 atherogenic lipid levels and higher risk of type 2 diabetes and coronary artery disease further 3 3 6 supporting the main findings from the scan of rare variants. Rare loss-of-function mutations in 3 3 7 PNPLA2 cause a recessively-inherited lipid storage disease characterized by ectopic fat 3 3 8 deposition, known as neutral lipid storage disease with myopathy, which in some of the few 3 3 9 reported cases has been associated with dyslipidemia and diabetes (49) (50) (51) (52) . Our study is suggesting that a deletion in hormone sensitive lipase (LIPE), present in ~5% of Amish people 3 4 3 but rarely detected in other populations, results in lower intracellular lipolysis, smaller adipocytes, insulin resistance and higher diabetes risk (53) . 3 4 5 Intracellular lipolysis is a pharmacologically modifiable pathway. The gene products of 3 4 6 ACVR1C and PNPLA2 have generated interest as potential drug targets for obesity and its improved glucose metabolism upon downregulation or pharmacologic inhibition of these 3 4 9 proteins. In our human genetic studies, the peripheral adiposity-increasing alleles at these genes
were associated with protection from diabetes (ACVR1C and PNPLA2) and coronary disease modulating these genes could protect from cardio-metabolic disease in humans. In addition, the product of PDE3B is inhibited by cilostazol, a non-selective inhibitor of both phosphodiesterase 3 5 4 3B and 3A used in cardiovascular medicine for its anti-platelet and vasodilating properties (58, 59). The interaction between PLIN1 and ABHD5 can also be inhibited pharmacologically, 3 5 6 resulting in enhanced PNPLA2 activity (60) . The association of variation in intracellular lipolysis 3 5 7 genes with multiple cardio-metabolic risk factors and outcomes in our study provides human 3 5 8 genetic evidence supporting further pharmacological development for this pathway. Also, the Coronary artery disease was defined as either (a) myocardial infarction or coronary disease in the hospitalization or death involving acute myocardial infarction or its complications (i.e. In addition to UK Biobank, genetic associations with type 2 diabetes were estimated from the
Conditional analyses and fine-mapping
At each associated genomic region, we conducted systematic analyses of the genomic context of associations. Our goal was to establish whether or not the identified rare nonsynonymous variants are likely to be the causal variants for the association with BMI-adjusted WHR. At each WHR, we conducted both approximate and formal conditional analyses. We considered the frequency using directly-genotyped and densely-imputed data using the Haplotype Reference Consortium. First, approximate conditional analyses were conducted on summary-level estimates using GCTA (79) to identify sets of conditionally-independent index genetic variants (p<5×10 -08 4 5 9 in the main or in sex-specific analyses and p<1.3×10 -06 in analyses using experiment-level linear regression models including all variants put forward from approximate analyses. Then, at 4 6 4 each region, we statistically decomposed the identified index signals by conditioning for the other 4 6 5 conditionally-independent index variants. We then performed Bayesian fine-mapping (80) to 4 6 6 estimate the posterior probability of association for each variant (PPA, where 0% indicates that
the variant is not causal and 100% indicates the highest possible posterior probability that the 4 6 8 variant is causal) and define the 99% credible set at that signal (i.e. a set of variants in a genomic 4 6 9 window that accounts for 99% of the PPA at that association signal). To perform credible set defined by:
where, BFj denotes the BF for the jth variant, and the denominator is the sum of BFs for all 4 7 4 included variants at that signal. A 99% credible set of variants was created by ranking the probability exceeded 0.99 (i.e. 99%). Additional associations with BMI-adjusted WHR at intracellular lipolysis regulators 4 7 9 The findings from our rare-variant scan led us to hypothesize that variation at key enzymes
of the intracellular lipolytic pathway might affect fat distribution (Fig. 4) . To test this hypothesis, we systematically investigated variation in and around the key regulators of each of the three adjusted WHR and estimated the burden of these variants using linear regression adjusted for age, 5 0 0 sex and genetic principal components comparing carriers to non-carriers of these rare alleles. Models were built with the MODELLER software (81) . Sequence alignment was achieved by HHpred, MUSCLE and Blast algorithms implemented in MPI toolkit (82) . Paralogues and orthologues were extracted from Orthologous Matrix database (83) , and displayed and edited in http://www.molsoft.com/icm_browser_pro.html).
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We used the Annovar (77) to generate annotations that predict deleteriousness of amino acid
changes. We generated the summary results of sixteen computational algorithms that predict whether or not an amino acid change is likely to be deleterious to the function of the encoded overall score of predicted deleteriousness (see SI Appendix Table S8 for details on the algorithms and scoring criteria).
1 5
We investigated the expression of the likely-causal genes in 53 tissues from the Genotype- Tissue Expression (GTEx) consortium (31) . Data were accessed from the online portal (URL:
https://www.gtexportal.org/home/) on the 1 st of September 2017. We performed pathway enrichment analyses using the ConsensusPathDB software (http://cpdb.molgen.mpg.de/) (85) . The software integrates data from 32 public databases to 5 2 0 identify pathways that are over-represented in a given gene list, providing a p-value for prevalence of genes of a given pathway in the list of interrogated genes (in this case the list of 12,355 genes available for analysis). Initial functional characterization of the PNPLA2 p.N252K variant 5 2 6 Given the central role of PNPLA2 in intracellular lipolysis and the existence of established experimental protocols for studying the impact of variants of this gene on hydrolytic activity 5 2 8 (86), we investigated the impact of the p.N252K variant. Green monkey kidney (Cos-7, ATCC and CRL-165) cells were seeded at 900,000 cells per 10 cm dish and transfected with: (a) human LacZ as a control using Metafectene. Twenty-eight hours after transfection, cells were harvested albumin as a standard. Expression of human wild-type PNPLA2 and human PNPLA2-N252K was verified by Western Blotting analysis. Triglyceride hydrolase activity assay was performed 5 3 6 as described previously (87) . A total of 20 µg of Cos-7 lysates containing overexpressed human 5 3 7 wild-type PNPLA2, human PNPLA2-N252K or LacZ as a control were incubated with 1µg acids was determined using liquid scintillation counting. Activity was measured in three technical 5 4 1 replicates, has been corrected for Cos-7 background activity (LacZ) and is presented as mean and individual results of three technical replicates.
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We also investigated the intracellular localization of wild-type and mutant PNPLA2. Cos-7 5 4 4 cells were seeded onto coverslips in 12 well tissue culture plates with a density of 60,000 cells per well and transfected with the following constructs: (a) human wild-type PNPLA2 tagged with catalytically inactive variant, (d) human PNPLA2 with both the N252K and S47A variants. Constructs were generated by site-directed mutagenesis using the Agilent primer design software described in the UK10K project (90) . RNAseq data from subcutaneous adipose tissue was 5 7 4 generated as described in Buil and colleagues (91) . Raw RNA reads were aligned to personal 5 7 5 genomes using the following strategy. The phased whole genome sequences from UK10K were 5 7 6 re-aligned to the human genome build GRCh37/hg37 to create diploid personal genomes for each 5 7 7 sample using vcf2diploid (92) . RNAseq reads were processed as follows. Adapter sequences 5 7 8 were trimmed from RNA-seq reads using TrimGalore, software that combines Cutadapt (93) and FastQC (URL: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Trimmed sequences 5 8 0 with less than 20 bases or which had Phred score below 1 were excluded. Poly-A tails longer than 4bp were trimmed with PRINSEQ-lite (94) . Processed reads were then aligned to the (STAR) (95) . Pairing of RNA-seq reads was evaluated for a Mapping Quality (MAPQ) score genomes were crosslinked to their genome locations on the reference genome with CrossMap v.0.2.3 (96) . A read's haplotype origin was assigned to either the haplotype with the least number of mismatches or assigned randomly to break ties. Uniquely mapped reads were retained and the 5 8 8 number of reads mapping to each haplotype was quantified with ASEReadCounter (97) . We Online data or software: 6 4 5 Human Splicing Finder (http://www.umd.be/HSF3/) Analyses are from 450,562 European ancestry individuals. Beta and standard errors are in standardized units of BMI-adjusted WHR per copy of the effect allele. Genomic coordinates according to human genome reference sequence GRCh37. * Adjusting for conditionally-independent index variants highlighted in the joint conditional model. † Using a p-value threshold p<1.3×10 -06 , corresponding to a Bonferroni correction for 37,435 genetic variants studied in this analysis. Abbreviations: SE, standard error; SD, standard deviation. ‡ Variant identified in the genome-wide scan of rare nonsynonymous variants. Abbreviations: SE, standard error; SD, standard deviation; PPA, posterior probability of association.
Figure Legends
Figure 1. Regional association plots of the overall and statistically-decomposed signals at the CALCRL, PLIN1, PDE3B and ACVR1C genes. Plots were drawn using LocusZoom (99) . Joint meta-analysis models using GCTA (79) were used at each locus to assess how many independent signals were present. Then, at each locus each signal was statistically-decomposed from others by estimating associations of all variants in the region adjusted for all other index variants at the region. Fine-mapping of each signal was performed using a Bayesian approach (80). 09 (-0.13, -0 09 (1.02, 1.17 
